It has been shown that artificial tears combinedwith recombinant bFGF (rbFGF) can improve the ocular surface function and enhancethe therapeutic effect on dry eyes after cataract surgery(8). The gene discussed is FGF2; the disease is Keratoconjunctivitis sicca.